UCSF - Medical Center
Dr. Fahy began working with RVV on Dec. 31, 2020. San Francisco had over 200 Hospitalized cases of Covid-19. Two weeks later there was about 160. On Jan 29 there was 122. At that same time there was about 50 cases in ICU with the larger ICU being at UCSF. On Jan 29. 20 in ICU at UCSF medical center. As well there would be 30 additional hospitalized patients at UCSF. Who is in charge of patient care in ICU at UCSF and would have significant influence (in the bay area) in standard care of hospitalized Covid-19 patients, not just at UCSF?
q "Dr. John Fahy, MD, MSc is a Professor of Medicine in the Division of Pulmonary and Critical Care Medicine and the Department of Medicine at the University of California San Francisco and is a director of UCSFs severe asthma clinic. He also cares for critically ill patients in the intensive care units and directs the UCSF Airway Clinical Research Center."
Now with his known thiol research, he would most likely be willing to give a thiol drug to a patient. What drug and company have a IND EAP for a thiol drug? Dr. Fahy isn't just reviewing the clinical results, he IS the EAP.
Am I connecting dots?
https://www.latimes.com/projects/california-coronavirus-cases-tracking-outbreak/san-francisco-county/